Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Ovid Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
OVID
Nasdaq
8731
https://ovidrx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Ovid Therapeutics Inc
We Think Ovid Therapeutics (NASDAQ:OVID) Can Afford To Drive Business Growth
- Apr 18th, 2024 10:08 am
Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
- Apr 4th, 2024 12:00 pm
Ovid Therapeutics Reaches US$197m Market Cap Benefiting Insider Stock Buying
- Mar 22nd, 2024 10:00 am
Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results
- Mar 8th, 2024 1:00 pm
Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
- Feb 28th, 2024 1:00 pm
Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Feb 6th, 2024 1:00 pm
Owning 31% shares,hedge funds owners seem interested in Ovid Therapeutics Inc. (NASDAQ:OVID),
- Jan 18th, 2024 12:25 pm
Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)
- Dec 1st, 2023 12:30 pm
Ovid Therapeutics (OVID) Upgraded to Buy: Here's Why
- Nov 9th, 2023 5:00 pm
Q3 2023 Ligand Pharmaceuticals Inc Earnings Call
- Nov 9th, 2023 1:48 pm
Ovid Therapeutics Inc (OVID) Reports Q3 2023 Financial Results
- Nov 6th, 2023 12:15 am
Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Updates
- Nov 3rd, 2023 12:00 pm
We're Not Very Worried About Ovid Therapeutics' (NASDAQ:OVID) Cash Burn Rate
- Oct 29th, 2023 12:11 pm
These 2 ‘Strong Buy’ Penny Stocks Have Massive Upside Potential, Says Oppenheimer
- Oct 19th, 2023 2:44 pm
Ovid Therapeutics and Ligand Pharmaceuticals Enter into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid’s Cash Runway into 2026
- Oct 18th, 2023 12:00 pm
Ovid Therapeutics to Present at the Jefferies Biotech CNS/Neuro Summit
- Oct 10th, 2023 12:00 pm
20 Countries With Highest Rate of Epilepsy
- Sep 29th, 2023 7:16 pm
Ovid Therapeutics to Host Investor Event - R&D Day on Monday, October 2, 2023
- Sep 26th, 2023 11:30 am
Ovid Therapeutics to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference
- Sep 20th, 2023 11:30 am
Ovid Therapeutics to Participate in Upcoming September Investor Conferences
- Aug 30th, 2023 12:00 pm
Scroll